Transcatheter Coil Embolization of Single Coronary Artery Fistula Using the Occlusion Test

Shin Takahashi1, Yurie Takizawa1, Satoshi Nakano1

  • 1Department of Pediatrics, School of Medicine, Iwate Medical University, Morioka, Japan.

Insights

The occlusion test safely assessed risks for coronary artery fistula embolization in a child with a single coronary artery. This pre-treatment evaluation helps identify potential myocardial ischemia and conduction issues.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Coronary artery fistulas (CAF) can pose risks during embolization, especially in complex cases like single coronary artery anomalies.
  • A pediatric patient presented with a significant coronary artery fistula to the right ventricle, causing coronary steal and narrowing the left coronary artery.

Observation:

  • Hemodynamic and electrocardiographic monitoring were performed during a 10-minute occlusion test of the proximal coronary artery fistula.
  • The patient had a single coronary artery anomaly with a large, porous fistula, increasing potential embolization risks.

Findings:

  • The occlusion test revealed no significant changes in pulmonary arterial pressure or aortic blood pressure.
  • No adverse events such as bradycardia, atrioventricular block, or ST changes were observed during the test.
  • These findings confirmed the safety of proceeding with coil embolization treatment.

Implications:

  • The occlusion test is a valuable tool for assessing the safety of embolization in complex coronary artery fistula cases.
  • This pre-procedural evaluation can identify patients at risk for myocardial ischemia and conduction system disorders.
  • It enables safer interventional planning for pediatric patients with single coronary arteries and distal fistulas.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
504
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
292
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
709
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
753